| Active substance | Medroxyprogesterone |
|---|---|
| Chemical name | Medroxyprogesterone acetate |
| Side effects | Weight gain, headache, nausea, menstrual irregularities, depression |
| Effects | Prevents ovulation, alters cervical mucus and endometrial lining |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Oral: 2.5-10 mg daily, Injectable: 150 mg every 3 months |
| Half-life | Approximately 50 days (injectable form), 17 to 24 hours (oral form) |
| Main action | Progestogenic agent |
| Substance class | Progestin |
| Formula | C24H34O4 |
| Storage conditions | Store at room temperature, protect from light |
| Trade name | Depo-Provera, Provera |
| Blood pressure | No significant effect |
| Also known as | MPA |
| Strength | 10mg |
| Lab Test | Hormone levels monitoring |
| Hepatotoxicity | Low |
| Water Retention | Minimal |
| Use in sports | Not typically used in sports |
| Manufacturer | Serum Institute Ltd. |
| Packing | 10 tabs/blister |
Meprate 10 mg Serum Institute Ltd.
€18.00
There are no reviews yet.